CALR-mutated myeloproliferative neoplasms: Refining molecular risk beyond the driver

Giuseppe G Loscocco1

  • 1Department of Experimental and Clinical Medicine, Center for Research and Innovation of Myeloproliferative Neoplasms (CRIMM), AOU Careggi, University of Florence, Florence, Italy.